CIK 0000718937 · Large accelerated filer
STAAR SURGICAL CO
Sign in to watch- Ticker
- STAA
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Jan 2
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953797439
- Phone
- 6263037902
- Business address
- 1911 WALKER AVE, MONROVIA, CA, 91016
- Former names
- STAAR SURGICAL COMPANY
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Grant or award · Stock Option (right to buy) | +8,952 | 8,952 | ||
| 2026-08-14 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Grant or award · Performance Stock Option (right to buy) | +29,159 | 29,159 | ||
| 2026-08-14 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise · Performance Stock Units | +5,233 | 41,452 | ||
| 2026-07-31 | Foust Warren President and CEO | Option exercise | +20,787 | 97,132 | ||
| 2026-07-31 | Foust Warren President and CEO | Shares withheld for taxes | −10,576 | $24.36 | $258K | 86,556 |
| 2026-07-31 | Foust Warren President and CEO | Option exercise · Restricted Stock Units | −20,787 | 0 | ||
| 2026-07-31 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise | +20,787 | 46,915 | ||
| 2026-07-31 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Shares withheld for taxes | −10,576 | $24.36 | $258K | 36,339 |
| 2026-07-31 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise · Restricted Stock Units | −20,787 | 0 | ||
| 2026-06-25 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise | +13,955 | 32,608 | ||
| 2026-06-25 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Shares withheld for taxes | −6,480 | $31.21 | $202K | 26,128 |
| 2026-06-25 | ANDREWS DEBORAH J Chief Financial Officer & EVP | Option exercise · Restricted Stock Units | −13,955 | 27,912 | ||
| 2026-06-18 | Wang Christopher Min Fang Director | Grant or award · Common Stock Option | +11,145 | 11,145 | ||
| 2026-06-18 | Zhou Lilian Yansheng Director | Grant or award · Restricted Stock Units | +3,091 | 3,091 | ||
| 2026-06-18 | Zhou Lilian Yansheng Director | Grant or award · Common Stock Options | +5,572 | 5,572 | ||
| 2026-06-18 | Jiang Wei Director | Option exercise | +10,683 | 77,127 | ||
| 2026-06-18 | Jiang Wei Director | Option exercise · Restricted Stock Units | −10,683 | 0 | ||
| 2026-06-18 | Jiang Wei Director | Grant or award · Restricted Stock Units | +6,182 | 6,182 | ||
| 2026-06-18 | Butcher Arthur C Director | Option exercise | +5,341 | 9,549 | ||
| 2026-06-18 | Butcher Arthur C Director | Option exercise · Restricted Stock Units | −5,341 | 0 |
Page 2 of 17 · 329 trades